Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 62,898 | 54,693 | 34,240 | 21,078 | 9,199 |
| Cost of Goods | 10,873 | 10,895 | 9,302 | 15,231 | 8,398 |
| Gross Profit | 52,025 | 43,798 | 24,938 | 5,847 | 801 |
| Operating Expenses | 50,188 | 55,410 | 44,548 | 40,595 | 34,362 |
| Operating Income | 2,710 | -10,717 | -19,308 | -34,517 | -33,163 |
| Other Income | -9,233 | -7,559 | -7,149 | -48,923 | 3,987 |
| Pre-tax Income | -6,523 | -18,276 | -26,457 | -83,440 | -29,176 |
| Net Income Continuous | -6,523 | -18,276 | -26,457 | -83,440 | -29,176 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -189 |
| Net Income | $-6,523 | $-18,276 | $-26,457 | $-83,440 | $-29,365 |
| EPS Basic Total Ops | -0.22 | -1.23 | -1.80 | -6.37 | -2.90 |
| EPS Basic Continuous Ops | -0.22 | -1.23 | -1.80 | -6.37 | -2.90 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -0.02 |
| EPS Diluted Total Ops | -0.22 | -1.23 | -1.80 | -6.37 | -2.90 |
| EPS Diluted Continuous Ops | -0.22 | -1.23 | -1.80 | -6.37 | -2.90 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.22 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $7,482 | $-6,109 | $-15,035 | $-30,263 | $-30,612 |